2023 annual financial data
BioLineRx 2023 Net margin
BioLineRx 2023 net margin with verified reported values.
Direct answer
Net margin was -1,262.79%.
Operating income was -49,694,000 USD and net income was -60,614,000 USD.
Operating cash flow was -22,608,000 USD.
Get free BioLineRx email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,800,000 USD
- Operating income
- -49,694,000 USD
- Net income
- -60,614,000 USD
- Operating cash flow
- -22,608,000 USD